Ergoteles’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,200
Closed -$410K 439
2023
Q2
$410K Buy
+32,200
New +$403K 0.02% 685
2022
Q4
Sell
-17,762
Closed -$206K 1662
2022
Q3
$206K Buy
+17,762
New +$244K 0.01% 1161
2022
Q2
Sell
-15,570
Closed -$301K 1810
2022
Q1
$301K Buy
+15,570
New +$278K 0.01% 836
2021
Q4
Sell
-96,400
Closed -$1.61M 1410
2021
Q3
$1.61M Buy
96,400
+74,600
+342% +$1.12M 0.06% 292
2021
Q2
$292K Buy
+21,800
New +$273K 0.01% 1081
2020
Q4
Sell
-13,600
Closed -$142K 787
2020
Q3
$142K Buy
+13,600
New +$173K 0.02% 515

Other funds holding INVA

Ergoteles's INVA Position: Q3 2023 in Review

Ergoteles sold out of Innoviva (INVA) in Q3 2023, closing a stake of 32,200 shares — an estimated $410K sold.

Ergoteles first reported a position in INVA in Q3 2020 and held it in 6 quarters. The position peaked at $1.61M in Q3 2021. 193 funds tracked by Wall St. Rank hold INVA as of Q3 2023.

  • Ergoteles reported no remaining Innoviva position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 32,200 Innoviva shares in Q3 2023, an estimated $410K.
  • Ergoteles first reported a position in Innoviva in Q3 2020 and held it in 6 quarters.
  • Ergoteles's Innoviva position peaked at $1.61M in Q3 2021.
  • 193 funds tracked by Wall St. Rank held Innoviva as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.